InsidersTradesSigma
Track the 메디쎄이 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 메디쎄이 has recorded 3 insider filings. Market capitalisation: €41.2bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: 동화약품. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
메디쎄이 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions for the medical field.